Activity

The 2019 AAMC statement on gender equity [2] indicated that a disproportionately small number of women (less than 25%) are represented among faculty in graduate science, technology, engineering, and mathematics (STEM) programs, particularly those who teach during the pre-clinical phase of undergraduate medical education.

101007/s40670-023-01776-1 provides the supplementary material for the online version.

The online version’s supplementary materials are situated at the provided URL: 101007/s40670-023-01776-1.

The practice of eliminating Structured Oral Examinations (SOE) is almost universally linked to their demonstrably weak psychometric characteristics. However, considering the different perspectives of the stakeholders could further elucidate its probable influence. This investigation into the matter involved focus groups and individual interviews with stakeholders, namely students, assessors, and school administrators. Students and assessors viewed the Student Observation Exercise (SOE) as an authentic assessment that provided a glimpse into students’ clinical reasoning, but one that was also acknowledged to be subjective and stressful. The administrators’ focus was on the organizational implications, specifically the logistical complexities. Making decisions regarding SOE necessitates a thorough examination of potential outcomes, and our results showcase the positive ramifications.

In the treatment of numerous malignancies, immune checkpoint inhibitors (ICIs) are now widely used and considered the gold standard. These agents, by augmenting the T cell immune response against cancerous tissues, have shown significant improvements in cancer treatment outcomes. s6kinase signal Improvements in ICI treatment notwithstanding, adverse kidney-related immune events (iRAEs) are an important consideration. Acute tubulo-interstitial nephritis, while remaining the leading cause of kidney iRAE, is increasingly observed with the presence of significant glomerular lesions and disruptions in electrolyte balance. Clinical features of kidney iRAEs, risk factors, and an analysis of current pathophysiologic mechanisms are comprehensively reviewed in this paper. We scrutinize the supporting evidence for guideline-advised ICI-associated kidney injury treatment, along with the deficiencies in present-day understanding. We advocate for a measured approach to kidney biopsy, aimed at detecting ICI-induced kidney injury, and the early administration of corticosteroids where indicated. Patients who have experienced kidney iRAE may also be eligible for a re-evaluation of ICI therapy, considering the current data on the recurrence rate of kidney injury. The balancing act between the possible advantages and disadvantages of a re-challenge must be addressed for each patient, with due consideration given to their individual preferences and the predicted course of their illness. Our final review of current knowledge surrounding the use of ICIs in end-stage renal disease, including kidney transplant recipients and those receiving dialysis, suggests that these patients ought not be automatically excluded from the potential advantages of these cancer treatments.

Hypertension plays a substantial role in the creation of cardiovascular diseases. While global hypertension incidence has surged, the molecular mechanisms responsible for its development are not entirely clear, largely because the pathogenesis is a complex interplay of several factors. A strong connection exists between blood pressure and salt intake, as reduced dietary salt is associated with decreased disease and death rates. This is further substantiated by hypertension’s role as a contributing factor in cardiovascular issues. Salt-sensitive individuals, unlike those with salt resistance, demonstrate a pronounced increase in blood pressure in response to variations in sodium consumption. Blood pressure regulation, within this scenario, is fundamentally dependent on the kidney, functioning under the control of the renin-angiotensin-aldosterone hormone system. Current molecular mechanisms for modulating blood pressure through renal ion channels/transporters, specifically including sodium-hydrogen exchanger isoform 3 (NHE3), Na+-K+-2Cl- cotransporter (NKCC2), sodium-chloride cotransporter (NCC), epithelial sodium channel (ENaC), and pendrin, which are present in diverse nephron segments, are concisely summarized in the present review. The deletion of renal ion channels in experimental animals has, in particular, yielded significant insights into several critical physiological mechanisms and molecules that influence the development of hypertension. These discoveries could lead to the development of novel therapeutic interventions for human hypertensive patients.

Acute kidney injury is a widespread and significant complication that is often encountered following hematopoietic stem cell transplantation. The nephrology community acknowledges that acute kidney injury is more than a temporary and potentially reversible drop in renal clearance; it substantially increases the risk of immediate and long-term complications. For this reason, stratifying patients for their risk of acute kidney injury following stem cell transplantation would be instrumental in enhancing care surrounding stem cell transplants, with the potential to improve the outcomes for this specific patient population. Mancianti et al.’s current CKJ report assesses kidney functional reserve in patients scheduled for stem cell transplantation. The study indicates that candidates with maintained kidney function under protein load had a higher possibility of full kidney recovery following acute kidney injury. This piece examines the functional reserve test of the kidney, exploring its limitations in this editorial.

We sought to determine whether renal functional reserve (RFR) could predict the risk of acute kidney injury (AKI) within 100 days of hematopoietic stem cell transplantation (HSCT), in addition to forecasting functional recovery or the possibility of chronic kidney disease development. Further investigation aimed to identify clinical and laboratory risk elements in the occurrence of AKI.

The study’s design was characterized by prospective observation. We recruited 48 patients, characterized by normal basal glomerular filtration rate (bGFR), who underwent allogeneic hematopoietic stem cell transplantation. Fifteen days before the HSCT, a multiparameter assessment, including the Renal Functional Reserve Test (RFR-T), was performed, which involved an oral protein load stress test.

Concordant bGFR readings were observed across multiple RFRs. From a cohort of 48 patients, acute kidney injury (AKI) developed in 29 (60%). When comparing individuals with and without acute kidney injury (AKI), no statistically significant distinctions were found across demographic, clinical, or multi-parameter assessment variables, except for the estimated glomerular filtration rate (eGFR). eGFR measures 100 milliliters per minute per 1.73 square meter of body surface area.

Fisher’s exact test highlighted a substantial relationship between the observed factor and the risk of developing AKI.

A discrepancy of only 0.001 necessitates further exploration. Patients with AKI+ presented lower RFR-T levels than those without AKI (28% versus 40%), but this discrepancy did not meet the criteria for statistical significance. Patients with AKI exhibiting renal function recovery rates greater than 20% (RFR) were more likely to achieve complete functional recovery, as assessed by a one-sided Fisher’s exact test.

A statistically insignificant correlation of 0.041 was found. The odds of not recovering surge dramatically when RFR reaches 20%, exhibiting a high odds ratio of 550 and a 95% confidence interval of 106 to 284.

Subclinical functional deterioration conditions, crucial for post-AKI recovery, are identified by RFR. The pre-HSCT eGFR level in our NKD cohort is a factor influencing the risk of AKI. A decrease in pre-HSCT renal reserve function by more than 20% is linked to full renal function recovery after AKI. The sequential assessment of eGFR, then RFR, could possibly identify patients who may benefit from changes to transplant strategies or timely nephrological interventions.

RFR’s role includes the identification of subclinical functional deterioration conditions, vital for post-AKI recovery. Within our group of patients without kidney disease (NKD), the pre-HSCT eGFR level demonstrated a connection to the risk of AKI. A reduction in the pre-HSCT renal functional reserve (RFR) exceeding 20% was linked with complete renal function restoration after AKI episodes. Prioritizing eGFR assessment followed by RFR evaluation could potentially identify patients suitable for adjustments in transplant protocols or early nephrological interventions.

Glomerular disease poses a considerable complication for individuals undergoing hematopoietic stem cell transplantation (HSCT), affecting roughly 1% to 2% of recipients, translating to 700 to 1400 cases annually across the globe. Multiple factors often contribute to the development of kidney disease post-HSCT, requiring a kidney biopsy to determine the specific disease origin and its impact on the kidney tissue. Kidney biopsy studies concerning the nephrotoxicity of HSCT, particularly glomerular disease, are surprisingly limited, primarily consisting of small series and case reports. HSCT can be accompanied by a variety of glomerular diseases. The disease spectrum, as described by Yap et al., is composed of (in descending order of frequency) thrombotic microangiopathy (387%), membranous nephropathy (258%), mesangial proliferative glomerulonephritis (129%), minimal change disease (97%), focal segmental glomerulosclerosis (97%), and membranoproliferative glomerulonephritis (32%). This editorial is a summary of the presented study and prior research that delves into the correlation between glomerular diseases and hematopoietic stem cell transplants.

In patients who have undergone haematopoietic stem cell transplantation (HSCT), various glomerular pathologies have been identified, but a robust understanding of their clinical-pathological correlations and the resulting patient outcomes remains insufficient.

The clinical and histopathological data of biopsied patients, whose diagnoses were confirmed, were analyzed by us.